TrialFrontiers in immunology2021

SARS-CoV-2 Spike Protein-Directed Monoclonal Antibodies May Ameliorate COVID-19 Complications in APECED Patients.

Elise M N Ferré et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.